Evidence map›Paper›PMID 41510255›Full record

ArticleResearch square2025

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling.

Tianshun Zhang, Qiushi Wang, Asad Khan, Chengcheng Hu, Emanuel Petricoin, Rebecca Morris, Sally Dickinson, Georg Wondrak, Ann M Bode, Clara Curiel-Lewandrowski

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Tianshun ZhangThe Hormel Institute, University of Minnesota.ORCID 0000-0001-7018-8393
Qiushi WangThe Hormel Institute, University of Minnesota.
Asad KhanThe Hormel Institute, University of Minnesota.
Chengcheng Hu3Department of Epidemiology and Biostatistics.
Emanuel PetricoinGeroge Mason University.
Rebecca MorrisThe Hormel Institute, University of Minnesota.
Sally DickinsonThe University of Arizona Cancer Center.
Georg WondrakUniversity of Arizona.ORCID 0000-0003-4799-8608
Ann M BodeUniversity of Minnesota.
Clara Curiel-LewandrowskiThe University of Arizona Cancer Center.

Funding

Targeted Prevention for Non-Melanoma Skin CancerP01CA229112 · NCI · UNIVERSITY OF ARIZONA · PI MANSOUR, HEIDI M. · 2019 to 2023
$7.1M
NCI NIH HHS P01 CA229112
6 · The paper itself

Abstract

Chronic ultraviolet (UV) exposure drives the development of non-melanoma skin cancers (NMSCs), particularly cutaneous squamous cell carcinoma (cSCC), through persistent DNA damage and inflammation. However, the molecular mediators that link genotoxic stress to tumor-promoting signaling and stromal activation remain poorly defined. Here, we identify CD70, a TNF superfamily member, as a UV- and DNA damage-inducible regulator that coordinates epithelial and stromal responses to promote skin carcinogenesis. Integrative analyses of transcriptomic (GTEx, GSE2503, GSE42677), proteomic (RPPA), and immunostaining datasets revealed marked upregulation of CD70 in sun-exposed skin, actinic keratoses, and cSCC lesions. Functionally, CD70 silencing suppressed cSCC proliferation and xenograft growth, whereas solar UV or DMBA exposure induced CD70 expression. Mechanistically, E2F1 directly bound and activated the CD70 promoter, establishing a transcriptional axis linking the DNA damage response to CD70 upregulation. CD70 depletion disrupted cytokine-receptor and MAPK/NF-κB signaling and altered inflammatory gene expression in UV-irradiated keratinocytes. In dermal fibroblasts, TGF-β-induced CD70 enhanced NF-κB activation and secretion of IL-6 and MCP3, thereby reinforcing paracrine inflammatory loops that supported cSCC spheroid expansion and tumor progression. CD70 knockdown in fibroblasts abrogated these effects and reduced tumor proliferation and cytokine expression in vivo. Collectively, our findings identify CD70 as a stress-inducible signaling hub that links DNA damage, inflammation, and tumor-stromal communication in skin carcinogenesis. Targeting CD70 may disrupt this feed-forward inflammatory circuit and provide a therapeutic strategy for inflammation-driven skin cancer.

Indexed as

CD70E2F1fibroblastsInflammatory signalingkeratinocytesnon-melanoma skin cancerUV-induced DNA damage

Identifiers

PMID41510255
PMCPMC12776433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.